Action mechanisms of modern antifungal agents and resulting problems in the management of onychomycosis

Mycoses

Volumn 46, Issue 11-12, 2003, Pages 506-510

  Seebacher, Claus ^a,b  

^a Municipal Hospital   (Germany)

^b NONE   (Germany)

Author keywords

Ciclopiroxolamine; Dormant dermatophytes; Onychomycosis; Terbinafine

Indexed keywords

ANTIFUNGAL AGENT; CICLOPIROXOLAMINE; TERBINAFINE;

ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFICACY; FUNGAL STRAIN; FUNGICIDAL ACTIVITY; FUNGUS GROWTH; FUNGUS SPORE; MICROSPORUM CANIS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; ONYCHOMYCOSIS; PRIORITY JOURNAL; RELAPSE; STRAIN DIFFERENCE; TREATMENT FAILURE; TRICHOPHYTON MENTAGROPHYTES;

ANTIFUNGAL AGENTS; COMBINED MODALITY THERAPY; HUMANS; MICROBIAL SENSITIVITY TESTS; MICROSPORUM; NAPHTHALENES; ONYCHOMYCOSIS; PYRIDONES; SPORES, FUNGAL; TRICHOPHYTON;

ARTHRODERMA BENHAMIAE; ARTHRODERMATACEAE; CANIS; FUNGI; MICROSPORUM; MICROSPORUM CANIS; TRICHOPHYTON;

EID: 0346216144     PISSN: 09337407     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.0933-7407.2003.00932.x     Document Type: Article

References (19)

1. Evans EGV, Sigurgeirsson B. Double blind, randomised study comparing continuous terbinafme with intermittent itraconazole in the treatment of toenail onychomycosis. Br Med J 1999; 318: 1031-5.
2. Sigurgeirsson B, Billstein S, Rantanen T et al. L.I.ON. Study: efficacy and tolerability of continuous terbinafine (Lamisil®) compared to intermittent itraconazole in the treatment of toenail onychomycosis. Br J Dermatol 1999; 141 (Suppl. 56): 5-14.
3. Epstein E. How often does oral treatment of toenail onychomycosis produce a disease-free nail? An analysis of published data. Arch Dermatol 1998; 134: 1551-4.
4. Tosti A, Piraccini MB, Stinchi C, Colombo MD. Relapses of onychomycosis after successful treatment with systemic antifungals: a three-year follow-up. Dermatology 1998; 197: 162-6.
5. Sigurgeirsson B, Olafsson JH, Steinsson JP, Paul C. Billstein S, Evans EGV. Long-term effectiveness of treatment with terbinafine vs. itraconazole in onychomycosis. A 5-year blinded prospective follow-up study. Arch Dermatol 2002; 138: 353-7.
6. Korting HC, Ollert M, Abeck D. Results of German multicenter study of antimicrobial susceptibilities of Trichophyton rubrum and Trichophyton mentagrophytes strains causing tinea unguium. Antimicrob Agent Chemother 1995; 39: 1206-8.
7. Ghannoum MA, Bradley M, Isham N, Leidich S, Elweski B. Genetic relatedness and antifungal susceptibilities of serial Trichophyton rubrum isolates from patients with onychomycosis of the toenail. Mycoses 1999; 42: 134 (Abstract).
8. Seebacher C. Grenzen der Kurzzeitbehandlung von Onychomykosen. Hautarzt 1998; 49: 705-8.
9. Balfour JA, Faulds D, Terbinafine. A review of its pharmacodynamic and pharmacokinetik properties, and therapeutic potential in superficial mycoses. Drugs 1992; 43: 259-84.
10. Faergemann J, Zehender H, Millerioux L. Levels of terbinafine in plasma, stratum corneum, dermis-epidermis (without stratum corneum, sebum, hair and nails) during and after 250 mg terbinafine orally once daily for 7 and 14 days. Clin experim Dermatol 1994; 19: 121-6.
11. Dittmar W, Lohaus G. HOE 296, a new antimycotic compound with a broad antimicrobial spectrum. Arzneim Forsch 1973; 23: 670-74.
12. Hänel H, Abrams B, Dittmar W, Ehlers G. A comparison of bifonazole and ciclopiroxolamine: in vitro, animal, and clinical studies. Mycoses 1988; 32: 632-40.
13. Stüttgen G, Bauer E. Bioavailability, skin and nail penetration of topically applied antifungals. Mykosen 1982; 25: 74-80.
14. Ceschin-Roques CG, Hänel H, Pruja-Bougaret SM, Luc J, Vandermander J, Michel G. Ciclopirox nail lacquer 8%: in vitro penetration into and through nails and in vitro effect on pig skin. Skin Pharmacol 1991; 4: 89-94.
15. Effendy I, Strassman K. Longitudinal studies on survivability and antifungal susceptibility of dermatophytes causing toenail mycosis. Mycoses 1999; 42: 172-3.
16. Grimmer H. Histologische Untersuchungen bei Nagelmykosen. In: Götz H (ed.), Die Griseofulvinbehandlung der Dermatomykosen. Berlin. Göttingen. Heidelberg: Springer, 1962: S74-78.
17. Roberrts DT, Evans EGV. Subungual dermatophytoma complicating dermatophyte onychomycosis. Br J Dermatol 1998; 138: 189-90.
18. Seebacher C, Kleine-Natrop HE, Kafka G. Die atraumatische Entfernung pilzinfizierter Nägel durch örtliche Anwendung von Kalium jodatum. Dermatol Monatsschr 1973; 159: 631-6.
19. Fräki JE, Heikkila HT, Kero MO et al. An open-label, noncomparative, multicenter evaluation of fluconazole with or without urea nail pedicure for treatment of onychomycosis. Cur Ther Res 1997; 58: 481-491.